Plasma concentrations of alanine (ALT) and aspartate (AST) aminotransferases have been classically regarded as markers of liver injury, including a wide range of etiologies from viral hepatitis to nonalcoholic fatty liver (NAFLD)1. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.